NASDAQ · Medical - Devices

PACB (PACB) Stock

$1.36 +0.00% NASDAQ: PACB Healthcare

Valuation

MetricValue
Price$1.36
Market Cap$422.42M
P/E Ratio-0.63
P/B Ratio71.44
P/S Ratio2.23
EPS (TTM)$-1.82
52-Week High$2.73
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10920.00%
ROA-69.64%
ROCE-11160.00%
Gross Margin-348.75%
Operating Margin-348.75%
Net Margin-80.34%
Debt/Equity297.29
Current Ratio6.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$131.0M$128.0M$201.0M$154.0M$160.0M
Operating Profit$-210.0M$-307.0M$-334.0M$-474.0M$-558.0M
Net Profit$-181.0M$-314.0M$-307.0M$-310.0M$-546.0M
EPS$-0.89$-1.40$-1.21$-1.07$-1.82
Op Margin-161.2%-239.4%-166.8%-308.0%-348.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$1.8B$1.7B$1.3B$784.0M
Total Liabilities$1.2B$1.2B$1.0B$754.0M$779.0M
Cash$461.0M$325.0M$180.0M$55.0M$64.0M
Borrowings$955.0M$948.0M$934.0M$672.0M$759.0M

Latest News

Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market Zacks · Jul 20, 2026 1 Small-Cap Stock Worth Investigating and 2 That Underwhelm StockStory · Jul 17, 2026 PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 15, 2026 Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know Zacks · Jul 13, 2026 Here's Why You Should Add PacBio Stock to Your Portfolio Now Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-111.0M$-263.0M$-267.0M$-206.0M$-111.0M
Investing Cash Flow$-684.0M$99.0M$-4.0M$118.0M$113.0M
Financing Cash Flow$-20.0M$0$-86.0M$0$0
Net Cash Flow$380.0M$-138.0M$-145.0M$-124.0M$8.0M
Free Cash Flow$-117.0M$-280.0M$-275.0M$-212.0M$-114.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-32.53%
Quick Ratio4.87
Interest Coverage-79.71
Return 1Y-17.16%
Return 3Y-89.14%
Return 5Y-94.44%

Ownership

Insiders Held8.77%
Institutions Held53.81%
Institutions Float Held58.99%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
BFLY $8.28 -1.72% -60.65 $2.20B 0.00%
DNA $8.07 -0.19% -1.30 $527.50M 0.00%
DRIO $7.47 -4.11% -10.51 $54.62M 0.00%
FLGT $18.53 -0.11% -8.10 $526.26M 0.00%

About PACB

PACB is led by CEO Christian O. Henry, employs 575 people, headquartered in US, publicly traded since 2010.

PACB stock trades at $1.36 with a market capitalization of $422.42M. The stock is valued at a price-to-earnings (P/E) ratio of -0.63, price-to-book of 71.44, price-to-sales of 2.23. Over the past 52 weeks the stock has ranged between $1.09 and $2.73, and currently trades 50.2% below its 52-week high.

On profitability, PACB generates a return on equity (ROE) of -10920.00%, return on capital employed of -11160.00%, an operating margin of -348.75%, a net profit margin of -80.34%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides